Molecular Diagnostics in Clinical Oncology
There are multiple applications of molecular tests in clinical oncology. Mutation analysis is now routinely utilized for the diagnosis of hereditary cancer syndromes. Healthy carriers of cancer-predisposing mutations benefit from tight medical surveillance and various preventive interventions. Cance...
Main Authors: | Anna P. Sokolenko, Evgeny N. Imyanitov |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Molecular Biosciences |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmolb.2018.00076/full |
Similar Items
-
Harmonization of Molecular Testing for Non-Small Cell Lung Cancer: Emphasis on PD-L1
by: Evgeny N. Imyanitov, et al.
Published: (2020-09-01) -
Breast cancer therapy for BRCA1 carriers: moving towards platinum standard?
by: Imyanitov Evgeny N
Published: (2009-04-01) -
Systemic therapy for hereditary cancer
by: Imyanitov Evgeny N
Published: (2012-12-01) -
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
by: Evgeny N. Imyanitov
Published: (2021-08-01) -
Cancer of Unknown Primary: Challenges and Progress in Clinical Management
by: Noemi Laprovitera, et al.
Published: (2021-01-01)